The Bioresorbable Medical Material Global Market Report 2023, provides comprehensive information on the bioresorbable medical material market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032
The global bioresorbable medical material market is expected to grow from .26 billion in 2022 to .4 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global bioresorbable medical material is expected to reach .04 billion in 2027 at a CAGR of 9.9%.
The introduction of novel biomaterials is a key trend gaining popularity in the bioresorbable medical material market. Major companies operating in the bioresorbable medical material market are focused on developing novel biomaterials for 3D printing applications to sustain their position in the market. For instance, in February 2020, Evonik Industries AG, a Germany-based specialty chemicals company specializing in bioresorbable materials, introduced RESOMER PrintPowder, the bioresorbable material in powder form suited for high-resolution 3D printing of implanted medical devices using selective laser sintering (SLS) machinery. This innovative product is a finely tuned, free-flowing powder with stringent specifications and an optimized particle size distribution. The exceptional flow properties of RESOMER PrintPowder enable medical device companies to leverage SLS 3D printing technologies to fabricate intricate bioresorbable implants with precisely customized mechanical characteristics.
The bioresorbable medical material market is segmented:
1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA) 2) By Application: Drug Delivery, Orthopedics, Other Applications 3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users
North America was the largest region in the bioresorbable medical material market in 2022.
Top 5 Major Key Players Are: Johnson & Johnson Abbott Laboratories Medtronic PLC Kureha Corporation Evonik Industries AG
Table Of Contents 1. Executive Summary 2. Bioresorbable Medical Material Market Characteristics 3. Bioresorbable Medical Material Market Trends And Strategies 4. Bioresorbable Medical Material Market - Macro Economic Scenario 5. Bioresorbable Medical Material Market Size and Growth ....... 32. Global Bioresorbable Medical Material Market Competitive Benchmarking 33. Global Bioresorbable Medical Material Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Bioresorbable Medical Material Market 35. Bioresorbable Medical Material Market Future Outlook and Potential Analysis 36. Appendix
Learn About Us: The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Like it? Share it!
About the Author
ramacharitbrc Joined: July 1st, 2020 Articles Posted: 1,888
